nach oben

European Child & Adolescent Psychiatry

Erschienen in:

01.02.2010 | Original Contribution

Does ADHD moderate the manifestation of anxiety disorders in children?

verfasst von: Paul Hammerness, Daniel Geller, Carter Petty, Alexis Lamb, Elyssa Bristol, Joseph Biederman

Erschienen in: European Child & Adolescent Psychiatry | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

The main aim of this study was to examine the moderating effects of attention deficit hyperactivity disorder (ADHD) on anxiety disorders in children. Data were analyzed from a large referred sample of children with anxiety disorder without comorbid ADHD (anxiety disorder, N = 253), anxiety disorder plus comorbid ADHD (anxiety disorder + ADHD, N = 704), and ADHD without comorbid anxiety disorder (ADHD, N = 511). Children were comprehensively assessed, including by structured diagnostic interview (K-SADS-E). Overall rates of individual anxiety disorders, as well as age of onset and severity of illness were not significantly different in the presence of comorbid ADHD. School functioning in children with anxiety disorders was negatively impacted by the presence of comorbid ADHD. Frequency of mental health treatment in children with anxiety disorders was significantly increased in the presence of comorbid ADHD. ADHD had a limited impact on the manifestation of anxiety disorder in children suggesting that ADHD and anxiety disorders are independently expressed.

Anderson JC, Williams S, McGee R, Silva PA (1987) DSM-III disorders in preadolescent children: prevalence in a large sample from the general population. Arch Gen Psychiatry 44:69–76PubMed

Biederman J, Faraone SV, Keenan K, Steingard R, Tsuang MT (1991) Familial association between attention deficit disorder and anxiety disorders. Am J Psychiatry 148:251–256PubMed

Biederman J, Faraone SV, Mick E, Williamson S, Wilens TE, Spencer TJ, Weber W, Jetton J, Kraus I, Pert J, Zallen B (1999) Clinical correlates of ADHD in females: findings from a large group of girls ascertained from pediatric and psychiatric referral sources. J Am Acad Child Adolesc Psychiatry 38:966–975PubMedCrossRef

Braaten E, Biederman J, Monuteaux M, Mick E, Calhoun E, Cattan G, Faraone S (2003) Revisiting the association between attention deficit hyperactivity disorder and anxiety disorders: a familial risk analysis. Biol Psychiatry 53:93–99CrossRefPubMed

Byun H, Yang J, Lee M, Jang W, Yang JW, Kim JH, Hong SD, Joung YS (2006) Psychiatric comorbidity in Korean children and adolescents with attention-deficit hyperactivity disorder: psychopathology according to subtype. Yonsei Med J 47:113–121CrossRefPubMed

Chavira DA, Stein MB, Bailey K, Stein MT (2004) Child anxiety in primary care: prevalent but untreated. Depress Anxiety 20:155–164CrossRefPubMed

Costello EJ, Egger HL, Angold A (2005) The developmental epidemiology of anxiety disorders: phenomenology, prevalence, and comorbidity. Child Adolesc Psychiatr Clin N Am 14:631–648 viiCrossRefPubMed

Diamond IR, Tannock R, Schachar RJ (1999) Response to methylphenidate in children with ADHD and comorbid anxiety. J Am Acad Child Adolesc Psychiatry 38:402–409CrossRefPubMed

Geller DA, Coffey B, Faraone S, Hagermoser L, Zaman NK, Farrell CL, Mullin B, Biederman J (2003) Does comorbid attention-deficit/hyperactivity disorder impact the clinical expression of pediatric obsessive-compulsive disorder? CNS Spectr 8:259–264PubMed

10.

Hollingshead AB (1975) Four factor index of social status. Yale Press, New Haven

11.

Masi G, Millepiedi S, Mucci M, Bertini N, Pfanner C, Arcangeli F (2006) Comorbidity of obsessive-compulsive disorder and attention-deficit/hyperactivity disorder in referred children and adolescents. Compr Psychiatry 47:42–47CrossRefPubMed

12.

MTA Cooperative Group (1999) A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal treatment study of children with ADHD. Arch Gen Psychiatry 56:1073–1086CrossRef

13.

Orvaschel H, Puig-Antich J (1987) Schedule for affective disorders and schizophrenia for school-age children: epidemiologic version. Nova University, Fort Lauderdale, FL

14.

Perrin S, Last CG (1996) Relationship between ADHD and anxiety in boys: results from a family study. J Am Acad Child Adolesc Psychiatry 35:988–996CrossRefPubMed

15.

Pliszka SR (1989) Effect of anxiety on cognition, behavior, and stimulant response in ADHD. J Am Acad Child Adolesc Psychiatry 28:882–887CrossRefPubMed

16.

Schatz DB, Rostain AL (2006) ADHD with comorbid anxiety: a review of the current literature. J Atten Disord 10:141–149CrossRefPubMed

17.

Spitzer RL, Williams JB, Gibbon M, First MB (1990) Structured clinical interview for DSM-III-R: non-patient edition (SCID-NP, Version 1.0). American Psychiatric Press, Washington, DC

18.

Tannock R, Ickowicz A, Schachar R (1995) Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety. J Am Acad Child Adolesc Psychiatry 34:886–896CrossRefPubMed

19.

Wang PS, Berglund P, Olfson M, Pincus HA, Wells KB, Kessler RC (2005) Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62:603–613CrossRefPubMed

20.

Wilens T, Biederman J, Brown S, Tanguay S, Monuteaux M, Blake C, Spencer T (2002) Psychiatric comorbidity and functioning in clinically referred preschoolers and school aged youth with ADHD. J Am Acad Child Adolesc Psychiatry 41:262–268CrossRefPubMed

Titel: Does ADHD moderate the manifestation of anxiety disorders in children?
verfasst von: Paul Hammerness
Daniel Geller
Carter Petty
Alexis Lamb
Elyssa Bristol
Joseph Biederman
Publikationsdatum: 01.02.2010
Verlag: D. Steinkopff-Verlag
Erschienen in: European Child & Adolescent Psychiatry / Ausgabe 2/2010
Print ISSN: 1018-8827
Elektronische ISSN: 1435-165X
DOI: https://doi.org/10.1007/s00787-009-0041-8

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2010

Cognitive coping and childhood anxiety disorders

Some clinical characteristics of children who survived the Marmara earthquakes

Co-morbidity and patterns of care in stimulant-treated children with ADHD in the Netherlands

The quality of life of children with attention deficit/hyperactivity disorder: a systematic review

The volumetric differences of the fronto-temporal region in young offspring of schizophrenic patients